Meeting
2019 Gastrointestinal Cancers Symposium
Activation of central/effector memory T cells in advanced gastric cancer patients treated with antiprogrammed death-1 antibody.
Authors
Hirofumi Ohmura
Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
Hirofumi Ohmura , Kyoko Yamaguchi , Fumiyasu Hanamura , Mamoru Ito , Akitaka Makiyama , Keita Uchino , Hozumi Shimokawa , Taito Esaki , Kenji Mitsugi , Yoshihiro Shibata , Hisanobu Oda , Kenji Tsuchihashi , Hiroshi Ariyama , Hitoshi Kusaba , Koichi Akashi , Eishi Baba
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Translational Research
Citation
J Clin Oncol 37, 2019 (suppl 4; abstr 54)
DOI
10.1200/JCO.2019.37.4_suppl.54
Abstract #
54
Poster Bd #
G4
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Exploring the potential of combination immune checkpoint strategies in non-small cell lung cancer (NSCLC).
First Author: Aakash Desai
Poster
2016 ASCO Annual Meeting
Association of methylation of homologous repair genes with expression of immune checkpoints in squamous cell carcinoma of head and neck, lung and cervix.
First Author: Damian Tobias Rieke
Poster
2023 ASCO Annual Meeting
Transforming growth factor-b1 and soluble co-inhibitory immune checkpoints as putative drivers of immune suppression in advanced basal cell carcinoma.
First Author: Bernardo Leon Rapoport
Poster
2020 ASCO Virtual Scientific Program
Targetable immune checkpoint molecules may be significantly differentially expressed in minority ethnicities.
First Author: Jacob J. Adashek